Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.01 USD | +3.61% | +4.21% | -0.07% |
Apr. 23 | Transcript : HealthStream, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 22 | Earnings Flash (HSTM) HEALTHSTREAM Posts Q1 Revenue $72.8M, vs. Street Est of $71.9M | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 880.7 | 691.8 | 832 | 759.4 | 818.6 | 821 | - | - |
Enterprise Value (EV) 1 | 880.7 | 691.8 | 832 | 759.4 | 818.6 | 821 | 821 | 821 |
P/E ratio | 55.5 x | 49.6 x | 146 x | 63.7 x | 54.1 x | 49.4 x | 44.9 x | - |
Yield | - | - | - | - | 0.37% | 0.41% | 0.41% | - |
Capitalization / Revenue | 3.47 x | 2.83 x | 3.24 x | 2.85 x | 2.93 x | 2.79 x | 2.65 x | 2.49 x |
EV / Revenue | 3.47 x | 2.83 x | 3.24 x | 2.85 x | 2.93 x | 2.79 x | 2.65 x | 2.49 x |
EV / EBITDA | 18.8 x | 15 x | 15.8 x | 14.2 x | 13.4 x | 12.4 x | 11.7 x | - |
EV / FCF | 30.2 x | 20.4 x | 48.8 x | 14.8 x | 22.8 x | 32.4 x | 29 x | 24.3 x |
FCF Yield | 3.31% | 4.9% | 2.05% | 6.74% | 4.39% | 3.08% | 3.45% | 4.11% |
Price to Book | 2.6 x | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 32,378 | 31,678 | 31,562 | 30,573 | 30,285 | 30,398 | - | - |
Reference price 2 | 27.20 | 21.84 | 26.36 | 24.84 | 27.03 | 27.01 | 27.01 | 27.01 |
Announcement Date | 2/18/20 | 2/22/21 | 2/21/22 | 2/20/23 | 2/19/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 254.1 | 244.8 | 256.7 | 266.8 | 279.1 | 294.1 | 309.9 | 330.4 |
EBITDA 1 | 46.87 | 45.99 | 52.68 | 53.44 | 61.3 | 66.08 | 69.96 | - |
EBIT 1 | 14.72 | 15.82 | 8.055 | 12.45 | 16.02 | 19.07 | 20.63 | 23.79 |
Operating Margin | 5.79% | 6.46% | 3.14% | 4.67% | 5.74% | 6.48% | 6.66% | 7.2% |
Earnings before Tax (EBT) 1 | 17.93 | 17.82 | 7.766 | 15.58 | 18.51 | 22.23 | 24.27 | - |
Net income 1 | 15.77 | 14.09 | 5.845 | 12.09 | 15.21 | 16.8 | 18.29 | - |
Net margin | 6.21% | 5.76% | 2.28% | 4.53% | 5.45% | 5.71% | 5.9% | - |
EPS 2 | 0.4900 | 0.4400 | 0.1800 | 0.3900 | 0.5000 | 0.5467 | 0.6017 | - |
Free Cash Flow 1 | 29.15 | 33.89 | 17.04 | 51.19 | 35.96 | 25.32 | 28.3 | 33.73 |
FCF margin | 11.47% | 13.84% | 6.64% | 19.18% | 12.89% | 8.61% | 9.13% | 10.21% |
FCF Conversion (EBITDA) | 62.18% | 73.69% | 32.34% | 95.78% | 58.67% | 38.31% | 40.44% | - |
FCF Conversion (Net income) | 184.83% | 240.48% | 291.51% | 423.36% | 236.4% | 150.68% | 154.67% | - |
Dividend per Share 2 | - | - | - | - | 0.1000 | 0.1100 | 0.1100 | - |
Announcement Date | 2/18/20 | 2/22/21 | 2/21/22 | 2/20/23 | 2/19/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 64.34 | 65.37 | 65.64 | 67.28 | 68.54 | 68.95 | 69.2 | 70.34 | 70.58 | 72.76 | 72.85 | 73.96 | 74.5 | 76.14 | 76.7 |
EBITDA 1 | 12.04 | 13.97 | 13.13 | 12.74 | 13.62 | 13.73 | 15.35 | 16.24 | 15.98 | 17.06 | 16.06 | 16.28 | 16.7 | 16.84 | 17.02 |
EBIT 1 | -0.46 | 4.035 | 2.953 | 2.382 | 3.079 | 2.891 | 4.008 | 4.863 | 4.256 | 5.69 | 4.354 | 4.417 | 4.604 | 4.892 | 4.676 |
Operating Margin | -0.71% | 6.17% | 4.5% | 3.54% | 4.49% | 4.19% | 5.79% | 6.91% | 6.03% | 7.82% | 5.98% | 5.97% | 6.18% | 6.42% | 6.1% |
Earnings before Tax (EBT) 1 | -0.499 | 3.759 | 3.632 | 4.925 | 3.27 | 3.141 | 4.5 | 5.453 | 5.418 | 6.543 | 5.087 | 5.186 | 5.41 | 5.759 | 5.571 |
Net income 1 | -0.387 | 2.893 | 3.083 | 3.666 | 2.451 | 2.623 | 4.133 | 3.867 | 4.59 | 5.227 | 3.76 | 3.831 | 3.986 | 4.404 | 4.258 |
Net margin | -0.6% | 4.43% | 4.7% | 5.45% | 3.58% | 3.8% | 5.97% | 5.5% | 6.5% | 7.18% | 5.16% | 5.18% | 5.35% | 5.78% | 5.55% |
EPS 2 | -0.0100 | 0.0900 | 0.1000 | 0.1200 | 0.0800 | 0.0900 | 0.1300 | 0.1300 | 0.1500 | 0.1700 | 0.1233 | 0.1283 | 0.1333 | 0.1400 | 0.1350 |
Dividend per Share 2 | - | - | - | - | - | - | - | 0.0250 | 0.0250 | - | 0.0300 | 0.0300 | 0.0300 | 0.0300 | 0.0300 |
Announcement Date | 2/21/22 | 4/25/22 | 7/25/22 | 10/24/22 | 2/20/23 | 4/24/23 | 7/24/23 | 10/23/23 | 2/19/24 | 4/22/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 29.1 | 33.9 | 17 | 51.2 | 36 | 25.3 | 28.3 | 33.7 |
ROE (net income / shareholders' equity) | 4.8% | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | 10.40 | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 22 | - | - | - | 28 | 29.7 | 29.5 | 31 |
Capex / Sales | 8.66% | - | - | - | 10.04% | 10.1% | 9.52% | 9.38% |
Announcement Date | 2/18/20 | 2/22/21 | 2/21/22 | 2/20/23 | 2/19/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.07% | 792M | |
+9.04% | 315B | |
+20.83% | 210B | |
-1.52% | 141B | |
+7.89% | 55.7B | |
+1.78% | 30.86B | |
+0.12% | 28.19B | |
+21.02% | 19.08B | |
+78.81% | 18.15B | |
-1.02% | 14.48B |
- Stock Market
- Equities
- HSTM Stock
- Financials HealthStream, Inc.